7 doctors weighed in:
Why don't cancer doctors prescribe zevalin (ibritumomab tiuxetan)?
7 doctors weighed in

Dr. Michael Thompson
Internal Medicine - Hematology & Oncology
4 doctors agree
In brief: Used
Doctors do prescribe zevalin (ibritumomab tiuxetan) (ibritumomab).
It is a useful medication, but the dosing involved a complex test dosing which was doable, but not available at all centers. That is better now. Also there is not "head-to-head" data vs the "naked" cd20 monoclonal antibody Rituximab vs. Zevalin, (ibritumomab tiuxetan) so some data are hard to interpret. It if more often used as consolidation or relapse therapy.

In brief: Used
Doctors do prescribe zevalin (ibritumomab tiuxetan) (ibritumomab).
It is a useful medication, but the dosing involved a complex test dosing which was doable, but not available at all centers. That is better now. Also there is not "head-to-head" data vs the "naked" cd20 monoclonal antibody Rituximab vs. Zevalin, (ibritumomab tiuxetan) so some data are hard to interpret. It if more often used as consolidation or relapse therapy.
Dr. Michael Thompson
Dr. Michael Thompson
Thank
Dr. Raymundo Romero
Internal Medicine - Oncology
3 doctors agree
In brief: WE DO
Zevalin (ibritumomab tiuxetan) is used with certain lymphomas.
It is not a first line therapy so it is given after other treatments have been given. Plus, there are other treatments which an oncologists may find more appropriate.

In brief: WE DO
Zevalin (ibritumomab tiuxetan) is used with certain lymphomas.
It is not a first line therapy so it is given after other treatments have been given. Plus, there are other treatments which an oncologists may find more appropriate.
Dr. Raymundo Romero
Dr. Raymundo Romero
Thank
Dr. Liawaty Ho
Internal Medicine - Hematology & Oncology
1 doctor agrees
In brief: Zevalin (ibritumomab tiuxetan)
Zevalin (ibritumomab tiuxetan) ( ibritumomab) is a radioimmuntherapy used to treat certain cases of lymphoma.
Cancer docs do use/prescribe zevalin (ibritumomab tiuxetan) in the right setting. Not as a first line treatment. It is mainly used in relapse or refractory disease.

In brief: Zevalin (ibritumomab tiuxetan)
Zevalin (ibritumomab tiuxetan) ( ibritumomab) is a radioimmuntherapy used to treat certain cases of lymphoma.
Cancer docs do use/prescribe zevalin (ibritumomab tiuxetan) in the right setting. Not as a first line treatment. It is mainly used in relapse or refractory disease.
Dr. Liawaty Ho
Dr. Liawaty Ho
Thank
Get help from a real doctor now
Dr. Adam Smith
Board Certified, Internal Medicine
13 years in practice
382K people helped
Continue
108,000 doctors available
Read more answers from doctors